NCT00897663已完成不适用
Optimizing EGFR Inhibitor-Based Therapies for GBM
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 56
- 试验地点
- 10
- 主要终点
- Molecular characteristics that predict for overall survival and progression-free survival
研究概览
简要总结
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.
PURPOSE: This laboratory study is looking at tissue samples from patients with glioblastoma multiforme to identify biomarkers that may improve the selection of patients for epidermal growth factor receptor inhibitor therapies.
详细描述
OBJECTIVES:
Primary
- Identify molecular characteristics that predict for overall survival and progression-free survival of patients treated with erlotinib hydrochloride, temozolomide, and radiotherapy on clinical trial NCCTG-N0177.
Secondary
- Identify molecular characteristics that predict for overall survival and progression-free survival of patients treated with gefitinib after radiotherapy on clinical trial NCCTG-N0074.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Molecular characteristics that predict for overall survival and progression-free survival
时间窗: Up to 24 months
次要结局
未报告次要终点
研究者
研究点 (10)
Loading locations...
相似试验
撤回
不适用
Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507Lung CancerNCT00907699Case Comprehensive Cancer Center
已完成
不适用
Biomarkers in Tumor Samples From Younger Patients With NeuroblastomaNeuroblastomaNCT01493830Children's Oncology Group5
招募中
不适用
Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung CancerLung CancerNCT00899405University of California, Davis800
已完成
不适用
Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid LeukemiaLeukemiaNCT00900380ECOG-ACRIN Cancer Research Group40
已完成
不适用
S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and PrednisoneLymphomaNCT00933127SWOG Cancer Research Network142